Hematological Malignancies (Blood Cancer) Program

Hematological Malignancies Infusion

Penn Medicine's Abramson Cancer Center's clinicians and researchers are leading the way in the diagnosis, treatment and research for hematologic malignancies (blood cancer).

We have one of the few Hematologic Malignancy Research Programs (leukemia, lymphoma and myeloma) in the country that is approved and funded by the National Cancer Institute. It is through this research program that we have made significant advances in improving bone marrow and stem cell transplants as well as improving the care of patients with blood cancer.

Our Hematological Malignancies Program offers:

  • Nationally recognized experts with extensive experience in hematologic malignancies
  • Advanced diagnostic testing, treatments and technologies
  • Coordinated care
  • Support services and education programs
  • A reputation for sensitivity and responsiveness
  • Personalized attention
  • Innovative clinical trials
  • The backing of a major research program with immediate translation of findings to patient care

Today, there's more hope than ever for those who face a blood cancer diagnosis. Our program is one of the oldest and largest in the country. By putting our experience to work, we offer the best possible treatment outcomes.

Our Hematologic Malignancies Program is comprised of the following programs:

A Premier Research Program

Since our discovery of the Philadelphia chromosome, which revolutionized cancer treatment, we've had a history of groundbreaking research. Our multidisciplinary hematologic malignancies team has dedicated their clinical and research careers to improving the field of hematologic malignancies. It is this relentless pursuit for the very best clinical outcome and quality of life that drives our Hematologic Malignancies Program.

Every day our scientists learn more about the causes of hematologic malignancies (leukemia, lymphoma and myeloma), as well as, better ways to prevent and detect them. Penn continues to be on the cutting-edge in the development of new therapies and the use of bone marrow and stem cell transplants to treat these cancers, all of which can make a difference to patients and their families, both today and in the future.

Our Team Approach

If you have been diagnosed with leukemia, lymphoma or multiple myeloma, you’ll want complete confidence in your medical team.

Our team includes physician specialists in medical oncology, surgical oncology, radiation oncology and pathology.

Your team will also include:

  • Patient support specialists: Our patient support specialists are experts in navigating complex health care situations. They serve as a consistent point of contact and a reliable source for support and direction for patients and families.
  • Cancer counselors: Our cancer counselors work exclusively with cancer patients and their families. They are available to provide individual, couples or family counseling. Our team includes a psychologist and psychiatrist who specializes in the issues that cancer patients face. Our cancer psychiatrist is available for counseling, prescribing medications and consulting with your team of Penn cancer specialists.
  • Registered dietitians: Our registered dietitians are available to provide nutritional counseling for patients being treated for cancer at the cancer center. Our dietitians specialize in cancer nutrition and provide information based on sound nutritional therapies.